Literature DB >> 12948027

Novel polyester-polysaccharide nanoparticles.

Caroline Lemarchand1, Patrick Couvreur, Madeleine Besnard, Dominique Costantini, Ruxandra Gref.   

Abstract

PURPOSE: The aim of the present study was to develop a new type of core-shell nanoparticles from a family of novel amphiphilic copolymers, based on dextran (DEX) grafted with poly(epsilon-caprolactone) (PCL) side chains (PCL-DEX).
METHODS: A family of PCL-DEX copolymers was synthesized in which both the molecular weight and the proportion by weight of DEX in the copolymer were varied. The nanoparticles were prepared by a technique derived from emulsion-solvent evaporation, during which emulsion stability was investigated using a Turbiscan. The nanoparticle size distribution, density, zeta potential, morphology, and suitability for freeze-drying were determined.
RESULTS: Because of their strongly amphiphilic properties, the PCL-DEX copolymers were able to stabilize o/w emulsions without the need of additional surfactants. Nanoparticles with a controlled mean diameter ranging from 100 to 250 nm were successfully prepared. A mechanism of formation of these nanoparticles was proposed. Zeta potential measurements confirmed the presence of a DEX coating.
CONCLUSION: A new generation of polysaccharide-decorated nanoparticles has been successfully prepared from a family of PCL-DEX amphiphilic copolymers. They may have potential applications in drug encapsulation and targeting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948027     DOI: 10.1023/a:1025017502379

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer.

Authors:  M T Peracchia; C Vauthier; D Desmaële; A Gulik; J C Dedieu; M Demoy; J d'Angelo; P Couvreur
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

2.  Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.

Authors:  P D Scholes; A G Coombes; L Illum; S S Davis; J F Watts; C Ustariz; M Vert; M C Davies
Journal:  J Control Release       Date:  1999-06-02       Impact factor: 9.776

3.  Design of folic acid-conjugated nanoparticles for drug targeting.

Authors:  B Stella; S Arpicco; M T Peracchia; D Desmaële; J Hoebeke; M Renoir; J D'Angelo; L Cattel; P Couvreur
Journal:  J Pharm Sci       Date:  2000-11       Impact factor: 3.534

4.  Surface modification of poly(lactic acid) nanospheres using hydrophobically modified dextrans as stabilizers in an o/w emulsion/evaporation technique.

Authors:  C Rouzes; R Gref; M Leonard; A De Sousa Delgado; E Dellacherie
Journal:  J Biomed Mater Res       Date:  2000-06-15

5.  Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG.

Authors:  E Osterberg; K Bergström; K Holmberg; T P Schuman; J A Riggs; N L Burns; J M Van Alstine; J M Harris
Journal:  J Biomed Mater Res       Date:  1995-06

6.  Biodegradable long-circulating polymeric nanospheres.

Authors:  R Gref; Y Minamitake; M T Peracchia; V Trubetskoy; V Torchilin; R Langer
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

7.  Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization.

Authors:  P Quellec; R Gref; L Perrin; E Dellacherie; F Sommer; J M Verbavatz; M J Alonso
Journal:  J Biomed Mater Res       Date:  1998-10

8.  Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.

Authors:  D Bazile; C Prud'homme; M T Bassoullet; M Marlard; G Spenlehauer; M Veillard
Journal:  J Pharm Sci       Date:  1995-04       Impact factor: 3.534

  8 in total
  5 in total

Review 1.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

Review 2.  Application of polysaccharides for surface modification of nanomedicines.

Authors:  Kyung-Oh Doh; Yoon Yeo
Journal:  Ther Deliv       Date:  2012-12

3.  Atorvastatin-loaded solid lipid nanoparticles as eye drops: proposed treatment option for age-related macular degeneration (AMD).

Authors:  Monika Yadav; Nicola Schiavone; Ana Guzman-Aranguez; Fabrizio Giansanti; Laura Papucci; Maria J Perez de Lara; Mandeep Singh; Indu Pal Kaur
Journal:  Drug Deliv Transl Res       Date:  2020-08       Impact factor: 4.617

4.  Self-assembled poly(ε-caprolactone)-g-chondroitin sulfate copolymers as an intracellular doxorubicin delivery carrier against lung cancer cells.

Authors:  Yue-Jin Lin; Yu-Sheng Liu; Hsin-Hwa Yeh; Tian-Lu Cheng; Li-Fang Wang
Journal:  Int J Nanomedicine       Date:  2012-08-01

5.  O-hexadecyl-dextran entrapped berberine nanoparticles abrogate high glucose stress induced apoptosis in primary rat hepatocytes.

Authors:  Radhika Kapoor; Shruti Singh; Madhulika Tripathi; Priyanka Bhatnagar; Poonam Kakkar; Kailash Chand Gupta
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.